Category Archives: Daily interesting IP news

Pharmaceutical inventions and patenting methods in India

We all are well aware of the fact that intense lobbying is happening on both to protect improvement inventions by innovator pharmaceutical companies and strategies to tackle these attempts by generic pharmaceutical companies. Pharmaceutical innovations are always treated special in … Continue reading

Posted in Daily interesting IP news | Tagged , , , | Leave a comment

Online filing of Indian patent application and practical difficulties

Recently, Indian patent office announced new fee structure and proposed some amendments [Patents (Amendment) Rules 2014] for filing/prosecuting Indian patent applications and now it is notified that those amendments are published in Gazette Of India, hence it is effective from the … Continue reading

Posted in Daily interesting IP news, e-filing module, Web databases | Leave a comment

Consolidation 2011

Disclaimer: This blog/post is an amateur effort Consolidated 2011 IP news INDIA First Patent Rules amendments: Indian Patent Office (IPO) published two draft patent rules amendments in 2011. The first one was on (Jan 2011) (Link) and second one was on (March … Continue reading

Posted in Daily interesting IP news | Leave a comment

AN UPDATE: India – Natco – Compulsory license

This is an update of Natco’s compulsory license application for Sorafenib and continuation of the earlier post. Controller of patent posted this CL opposition hearing on Jan 06, 2012. (DNA article). Bayer/patentee has sought for adjournment of this hearing (copy of … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | Leave a comment

Mexico: Medicine Patent journal updated

Mexico INPI has updated new medicine patent journal last week. [December 2011] After April 2011 update, MX INPI has updated some addendum to the journal like [July 2011] [July 2011] [July 2011] [August 2011] [Aug 2011] [Aug 2011] [Oct 2011] … Continue reading

Posted in Daily interesting IP news, Web databases | Tagged , , | Leave a comment

Madras High Court – Erlotinib patent infringement suits

[Business Line] [India Infoline] [Order] We are aware that Roche has filed patent infringement suit against some companies (Intas, Matrix) in Madras High Court which is related to Erlotinib and the patent No. 196774. Both of the suits and connected … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , , | Leave a comment

Lipitor generic predictions

As Nov 30 approaches and Pfizer prepares to lose exclusivity on Lipitor, analysts are offering a variety of theories [Settelement bwt Ranbaxy and Pfizer] =============================================================== ….Two of Ranbaxy’s India plants have been banned by the USFDA. While Ranbaxy is confident … Continue reading

Posted in Daily interesting IP news, Ranbaxy | Tagged , , | Leave a comment

Presumption of patent validity in granting interim injunction

[Order] [SpicyIP] A granted patent can not be presumed to be valid. The presumption of patent validity is very less when defendant shows substantial doubts on violation of procedures in patent grant and credible challenge on patentibility and also when patent is granted recently. … Continue reading

Posted in Daily interesting IP news, Patent case, Uncategorized | Tagged , , | Leave a comment

Bayer Vs Controller of patents

[SpicyIP] [Order] Yesterday, a interesting news is posted in SpicyIP blog.  Bayer challenges ambiguity in statutory language of “prima facie case” of section 87(1). Controller has published Natco’s compulsory license as per section 87(1) as prima facie case made out (published on Aug 12th … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | 1 Comment

Ranbaxy-MMV-Antimalarial

Today Economic times reported that Ranbaxy received conditional approval for combination of its NCE molecule (Arterolane) and piperaquine phosphate. Drug Controller General of India ( DCGI) Surinder Singh said the marketing licence was subject to the condition that the Chinese plant … Continue reading

Posted in Daily interesting IP news, Drug developments & targets | Tagged , , , | 1 Comment